How to Get Epiduo Online in Mérida

If you want to get Epiduo online in Mérida, you can consult an EU-licensed doctor without the weeks-long wait for an in-person dermatology appointment. Hi-Doctor provides a structured, asynchronous medical assessment for patients dealing with mild-to-moderate inflammatory acne. You complete an online clinical questionnaire, upload clear photos of your skin, and receive a medical decision from a registered physician. When clinically appropriate, a downloadable REMPE electronic prescription is issued in under 24 hours for a flat 40 € consultation fee, usable at any pharmacy in Mérida or across the EU.

How it works — get your consultation in 4 steps

Acquiring an acne treatment plan does not require taking time off work to visit a clinic in Mérida. The consultation is entirely asynchronous, private, and RGPD-compliant.

1. Complete the medical questionnaire: Answer targeted questions about your acne history, previous treatments, and overall health.
2. Upload clear photos: Provide well-lit photographs of the affected areas (face, chest, or back) so the doctor can assess lesion morphology and severity.
3. Doctor evaluation: An EU-licensed doctor reviews your file and photographic evidence. If treatment is clinically indicated, they issue an official REMPE prescription within 24 hours.
4. Present your prescription: Download the prescription PDF directly from your Hi-Doctor account. Present the digital QR code or a printed copy at any local pharmacy in Mérida or across the EU.

Who qualifies

Epiduo (a fixed-dose combination of adapalene 0.1% and benzoyl peroxide 2.5%) is indicated for the topical treatment of acne vulgaris when both comedones (blackheads and whiteheads) and inflammatory lesions (papules and pustules) are present. When you apply to get Epiduo online, the doctor evaluates your clinical profile against strict safety parameters.

You may qualify if you are an adult or adolescent over 9 years old experiencing mild-to-moderate facial or truncal acne that has not responded adequately to single-agent over-the-counter products.

Out of scope conditions

Hi-Doctor's dermatology pathway is strictly limited to topical therapies. The following cases cannot be managed through our online consultation and require in-person medical evaluation:

• Severe nodulocystic or conglobate acne: Deep, painful cysts require specialist physical examination and potential systemic therapy.
• Scarring acne: Active, destructive acne causing permanent tissue loss.
• Systemic therapy candidates: Hi-Doctor does not prescribe oral isotretinoin (Roaccutane) or oral antibiotics for acne.
• Pregnancy and breastfeeding: Topical retinoids like adapalene are contraindicated during pregnancy; alternative agents like azelaic acid 15% are preferred.

Treatment Option	Active Ingredients	Primary Clinical Indication	Hi-Doctor Consultation Fee
Epiduo Gel	Adapalene 0.1% + Benzoyl Peroxide 2.5%	Comedonal & mild-to-moderate inflammatory acne	40 € (one-off)
Skinoren / Finacea	Azelaic Acid 15% Gel	Acne in pregnancy, sensitive skin, hyperpigmentation	40 € (one-off)
Duac Gel	Clindamycin 1% + Benzoyl Peroxide 3%/5%	Short-term inflammatory flare-ups (max 12 weeks)	40 € (one-off)
Oral Isotretinoin	Isotretinoin	Severe, nodulocystic, treatment-resistant acne	Out of scope (referral only)

What Epiduo actually does

Epiduo combines two complementary active mechanisms into a single once-nightly gel, addressing multiple pathophysiological factors of acne simultaneously without relying on topical antibiotics.

• Adapalene 0.1%: A stable, third-generation synthetic retinoid. It binds selectively to nuclear retinoic acid receptors (RAR-beta and RAR-gamma), normalising follicular keratinisation, unblocking plugged pores (comedolysis), and exerting direct anti-inflammatory effects.
• Benzoyl Peroxide 2.5%: A potent lipophilic antimicrobial agent. Upon application, it decomposes to release free oxygen radicals that rapidly eradicate Cutibacterium acnes inside the sebaceous follicle. Because its mechanism is oxidising rather than biochemical, bacteria cannot develop resistance to it.

Clinical expectation: Most patients experience a retinoid purge between weeks 2 and 6 as microcomedones accelerate to the surface. True clinical improvement is formally evaluated at 12 weeks of consistent nightly use.

Side effects and when to stop

Local cutaneous reactions are common during initial application as the stratum corneum adapts to increased cell turnover. Most symptoms are mild to moderate and peak during the first 2–4 weeks.

• Common reactions: Erythema (redness), scaling, skin dryness, stinging, and a mild burning sensation.
• Management: Apply a thin pea-sized layer to dry skin 20 minutes after cleansing. Use a non-comedogenic moisturiser immediately afterwards. Always apply broad-spectrum SPF 50+ sunscreen in the morning, as retinoids increase photosensitivity.
• When to discontinue: Stop treatment and consult a healthcare provider if you experience severe contact dermatitis, facial swelling, eyelid oedema, or signs of an allergic reaction. Note that benzoyl peroxide will bleach hair, clothing, and bed linen upon contact.

Why Hi-Doctor vs. walking into a clinic

Securing a dermatology consultation in Mérida through traditional healthcare routes can involve long wait times or high private clinic fees. Hi-Doctor streamlines your access to accredited healthcare.

Over 50,000 patients have accessed care through Hi-Doctor, backed by an independent 4.8/5 Trustpilot rating.

• No appointment queues: Fill out the clinical questionnaire whenever convenient from your phone or laptop.
• No financial risk: The 40 € consultation fee is protected by our money-back guarantee. If the reviewing doctor determines that Epiduo is clinically inappropriate for your skin, you receive a full refund.
• Official REMPE system: Prescriptions are issued through Spain's official private electronic prescription standard (Receta Médica Privada Electrónica). In Spain, pharmacists validate the code against the central registry. Under Directive 2011/24/EU and Commission Implementing Directive 2012/52/EU, the prescription PDF contains all cross-border identifying data, meaning pharmacists across the EU may review the document and dispense the medication or a local equivalent (pharmacists retain the right to refuse dispensing under professional discretion).